rozlytrek
roche registration gmbh - entrectinib - cancer; carcinoma, non-small-cell lung - daganatellenes szerek - rozlytrek as monotherapy is indicated for the treatment of adult and paediatric patients 12 years of age and older with solid tumours expressing a neurotrophic tyrosine receptor kinase (ntrk) gene fusion,who have a disease that is locally advanced, metastatic or where surgical resection is likely to result in severe morbidity, andwho have not received a prior ntrk inhibitorwho have no satisfactory treatment options. rozlytrek as monotherapy is indicated for the treatment of adult patients with ros1 positive, advanced non small cell lung cancer (nsclc) not previously treated with ros1 inhibitors.
pregagamma 25 mg kemény kapszula
wörwag pharma gmbh&co.kg - pregabalin -
pregagamma 75 mg kemény kapszula
wörwag pharma gmbh&co.kg - pregabalin -
pregagamma 150 mg kemény kapszula
wörwag pharma gmbh&co.kg - pregabalin -
vilarib 200 mg kemény kapszula
pharmaswiss ceska republika s.r.o - ribavirin -
pregabalin stada 75 mg kemény kapszula
stada arzneimittel ag - pregabalin -
pregabalin stada 150 mg kemény kapszula
stada arzneimittel ag - pregabalin -
adepend 50 mg filmtabletta
orpha devel handels und vertriebs gmbh - naltrexone -
caverject 10 mikrogramm por és oldószer oldatos injekcióhoz
pfizer kft. - alprostadil -
caverject 20 mikrogramm por és oldószer oldatos injekcióhoz
pfizer kft. - alprostadil -